L
LTRN
Lantern Pharma Inc
0.7370
-0.0757-9.31%After Hours: 0.7264 -0.0106 -1.44%19:30 10/12 EDT
OPEN/PREV CLOSE0.8490/0.8127
TODAY RANGE0.7201-0.8500
VOL184.05K
MARKET CAP11.01M
52 WEEK RANGE0.7201-4.580
AVG VOL (3M)182.95K
% TURNOVER1.21%
TURNOVER--
P/E (TTM)-0.4564
% RANGE15.98%
EPS(TTM)-1.6148
P/E(FORWARD)-0.4521
P/B-2.9223
BVPS-0.2522
DIVIDEND--
P/S1.195
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP9.10M
SHARES OUTSTANDING14.94M
NEXT EARNINGS11/11-11/16
FREE FLOAT12.34M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·10/01 20:35
Lantern Pharma Faces Nasdaq Non-Compliance, Delisting Risk
TipRanks·09/30 20:35
Lantern Pharma Raises Capital Through Recent Securities Offerings
Benzinga·09/29 21:06
12 Health Care Stocks Moving In Tuesday's After-Market Session
TipRanks·09/29 12:15
Lantern Pharma prices 3.67M shares at $1.09 in registered direct offering
Seeking Alpha·09/29 12:08
Lantern Pharma announces up to $8M registered direct offering
TipRanks·09/24 10:31
Lantern Pharma Highlights Open-Medicine AI Oncology Platform
TipRanks·09/23 12:21
Lantern Pharma Showcases Open-Medicine AI Growth Strategy
TipRanks·09/22 11:50
Lantern Pharma secures USPTO notice of allowance for LP-284 patent
Benzinga·09/18 12:47
Lantern Pharma Q2 2026 Earnings Call: Complete Transcript
TipRanks·09/17 12:25
Lantern Pharma to host webinar on Open-Medicine AI
TipRanks·08/25 00:22
Lantern Pharma Earnings Call: AI Spinout, Trial Momentum
TipRanks·08/14 11:59
Lantern Pharma Forms Open Medicine AI Subsidiary Business
Benzinga·08/14 11:43
Lantern Pharma Q2 EPS $(0.57) Misses $(0.38) Estimate
Same Industry
Name/Symbol
Change%
Price